Login

CYNOSURE INC

No Longer Reporting

The company has not filed an annual or quarterly report since its FY2016 10-K, filed Feb 28, 2017. Its latest SEC filing is a SC 13G/A from Feb 9, 2018.

The sections below describe the company as of the FY2016 annual report.

What Did They Do?

Develops, makes and sells laser-, light- and radiofrequency-based medical systems for aesthetic treatments and precision surgery to physicians and other medical practitioners.

How Did They Make Money?

Customers pay for systems, parts and accessories when they ship; service and extended-warranty fees are spread over the contract period, and license royalties come in when licensees report sales, sometimes a quarter after the sale.

FY2016 revenue

Who Were Their Customers?

Physicians buy directly in North America and in countries where Cynosure has its own sales teams; independent distributors sell, install and service products in other international markets.

Did Revenues Turn Into Profits?

Yes. It kept 3 cents of every revenue dollar as net income in FY2016.

Operating income, FY2016
6% of revenue
▲ +4% vs FY2015 ($26.3M, 8%)
Net income, FY2016
3% of revenue
▼ −10% vs FY2015 ($15.8M, 5%)

How Were They Changing?

Since the FY2016 annual report
  • Mar 23, 2017 Cynosure became a wholly owned subsidiary after merger The company also requested that Nasdaq suspend trading and delist its shares.

Grew. Revenue grew 2.8x in 4 years, from $153.5M in FY2012 to $433.5M in FY2016, about 30% a year.

Who Did They Compete With?

Competes with Cutera, Syneron Medical, ZELTIQ Aesthetics, Alma Lasers, and Lumenis

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support